Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis-Reference-Cited by-同舟云学术

Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis

Published:2019-04-04 Issue:1 Volume:39 Page:17
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

You Xin¹²,Jiang Weiye¹,Lu Wenhua¹,Zhang Hui³,Yu Tiantian³,Tian Jingyu¹,Wen Shijun¹,Garcia-Manero Guillermo⁴,Huang Peng¹³,Hu Yumin¹³

Affiliation:

1. Department of Experimental Therapeutics; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine; 651 Dong Feng East Road Guangzhou 510060 Guangdong P. R. China

2. The First Department of Chemotherapy; The First Affiliated Hospital of Fujian Medical University; Fuzhou 350005 Fujian P. R. China

3. Metabolic Innovation Center, Zhongshan School of Medicine; Sun Yat-sen University; Guangzhou 510080 Guangdong P. R. China

4. Department of Leukemia; The University of Texas M.D. Anderson Cancer Center; Houston TX 77030 USA

Funder

Natural Science Foundation of Guangdong Province

Guangzhou Medicare Collaborative Innovation Program

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-019-0362-z.pdf

Reference27 articles.

1. Treatment of FLT3-ITD positive acute myelogenous leukemia with allogeneic and autologous stem cell transplantation-results in 175 patients;Thiede;Blood.,2002

2. Phase I study of sorafenib in patients with refractory or relapsed acute leukemias;Borthakur;Haematologica,2011

3. Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status;Cortes;J Clin Oncol.,2013

4. Drug resistance in mutant FLT3-positive AML;Weisberg;Oncogene,2010

5. Secondary mutations as mediators of resistance to targeted therapy in leukemia;Daver;Blood,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of biological signatures of cruciferous vegetable consumption utilizing machine learning-based global untargeted stable isotope traced metabolomics;Frontiers in Nutrition;2024-07-03

2. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer;Nature Communications;2024-04-24

3. Cancer Drug Resistance and Metabolic Reprogramming;Drug Resistance in Cancer: Mechanisms and Strategies;2024

4. Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy;Scientific Reports;2023-12-09

5. Analysis of the Inhibitory Effect of hsa-miR-145-5p and hsa-miR-203a-5p on Imatinib-Resistant K562 Cells by GC/MS Metabolomics Method;Journal of the American Society for Mass Spectrometry;2023-09-14